FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

331828002: Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3692869013 Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692871013 Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
468563019 Betamethasone+salicylic acid 0.05/3% ointment en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
468563019 Betamethasone+salicylic acid 0.05/3% ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
721426011 Betamethasone+salicylic acid 0.05/3% ointment (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1192588019 Betamethasone+salicylic acid 0.05/3% ointment (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1192588019 Betamethasone+salicylic acid 0.05/3% ointment (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692869013 Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692870014 Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692871013 Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Is a Product containing betamethasone and salicylic acid (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Betamethasone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Salicylic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent kératolytique false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent topique false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has manufactured dose form forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Is a Topical betamethasone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Is a Product containing salicylic acid in topical dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has manufactured dose form Cutaneous ointment true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength denominator unit (attribute) g true Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength denominator unit (attribute) g true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has basis of strength substance (attribute) Betamethasone true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength numerator unit mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength numerator value 30 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has basis of strength substance (attribute) Salicylic acid (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has precise active ingredient Salicylic acid (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has concentration strength numerator unit mcg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has precise active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Is a Betamethasone and salicylic acid only product in cutaneous dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Plays role Antifungal therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start